Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: Efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro

Blood

Volumn 89, Issue 7, 1997, Pages 2283-2290

  Su, Lishan ^a   Lee, Robert ^a   Bohyhadi, Mark ^a   Matsuzaki, Hajime ^a   Forestell, Sean ^a   Escaich, Sonia ^a   Böhnlein, Ernst ^a   Kaneshima, Hideto ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; LYT ANTIGEN; MESSENGER RNA; VIRUS VECTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SELECTION; CELL TRANSPLANTATION; CENTRIFUGATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SCID MOUSE;

EID: 0030970792     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.7.2283     Document Type: Article

References (49)

1. Baltimore D: Intracellular immunization. Nature 335:395, 1988
2. Gilboa E, Smith C: Gene therapy for infectious diseases: The AIDS model. Trends Genet 10:139, 1994
3. Bridges SH, Sarver N: Gene therapy and immune restoration for HIV disease. Lancet 345:427, 1995
4. Fauci AS: Multifactorial nature of human immunodeficiency virus disease: Implications for therapy. Science 262:1011, 1993
5. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 57:183, 1993
6. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 89:2804, 1992
7. Brenner M: Current status of gene transfer into haemopoietic progenitor cells: Application to Langerhans cell histiocytosis. Br J Cancer Suppl 23:56, 1994
8. Nienhuis AW: Gene transfer into hematopoietic stem cells. Blood Cells 20:141, 1994
9. Moritz T, Keller DC, Williams DA: Human cord blood cells as targets for gene transfer: Potential use in genetic therapies of severe combined immunodeficiency disease. J Exp Med 178:529, 1993
10. Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE: High efficiency retroviral mediated gene transduction into single isolated immature and replatable CD34+ hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 178:2089, 1993
11. Hanley ME, Nolta JA, Parkman R, Kohn DB: Umbilical cord blood cell transduction by retroviral vectors: Preclinical studies to optimize gene transfer. Blood Cells 20:539, 1994
12. Yu M, Leavitt MC, Maruyama M, Yamada O, Young D, Ho AD, Wong-Staal F: Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 92:699, 1995
13. Malim MH, Böhnlein S, Hauber J, Cullen BR: Functional dissection of the HIV-1 Rev trans-activator - Derivation of a trans-dominant repressor of Rev function. Cell 58:205, 1989
14. Cullen BR: Regulation of human immunodeficiency virus replication. Annu Rev Microbiol 45:219, 1991
15. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ: Stable expression of transdominant Rev protein in human T cells inhibts human immunodeficiency virus replication. J Exp Med 176:1197, 1992
16. Bevec D, Dobrovnik M, Hauber J, Böhnlein E: Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator, Proc Natl Acad Sci USA 89:9870, 1992
17. Escaich S, Kalfoglou C, Plavec I, Kaushal S, Mosca JD, Böhnlein E: RevM10-mediated inhibition of HIV-1 replication in chronically infected T cells. Hum Gene Ther 6:625, 1995
18. Vandendriesche T, Chuah MKL, Chiang L, Chang HK, Ensoli B, Morgan RA: Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes. J Virol 69:4045, 1995
19. Fox BA, Woffendin C, Yang Z-Y, San H, Ranga U, Gordon D, Osterholzer J, Nabel GJ: Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: Safety and toxicity. Hum Gene Ther 6:997, 1995
20. Rigg RJ, Dando JS, Escaich S, Plavec I, Bohnlein E: Detection of intracellular HIV-1 Rev protein by flow cytometry. J Immunol Methods 188:187, 1995
21. Tagawa TL, Nakauchi H, Herzenberg LA, Nolan GP: Formal proof that different-size Lyt2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc Natl Acad Sci USA 83:3422, 1986
22. Adam MA, Ramesh N, Miller D, Osborne WA: Internal initiation of translation in retroviral vectors carrying picornavirus 5′ non-translated regions. J Virol 65:4985, 1991
23. Forestell SP, Böhnlein E, Rigg RJ: Retroviral end-point titer is not predictive of gene transfer efficiency: Implications for vector production. Gene Ther 2:723, 1995
24. DiGiusto DL, Lee R, Moon J, Moss K, O'Toole T, Voytovich A, Webster D, Mulé JJ: Hematopoietic potential of cryopreserved and ex-vivo manipulated cord blood progenitors evaluated in vitro and in vivo. Blood 87:1261, 1996
25. Bahnson AB, Dunigan JT, Baysal BE, Mohney T, Atchinson RW, Nimgaonkar MT, Ball ED, Barranger JA: Centrifugal enhancement of retroviral-mediated gene-transfer. J Virol Methods 54:131, 1995
26. Kyoizumi S, Baum CM, Kaneshima H, McCune JM, Yee EJ, Namikawa R: Implantation and maintenance of functional human bone marrow in SCID-hu mice. Blood 79:1704, 1992
27. Chen BP, Galy A, Kyoizumi S, Namikawa R, Scarborough J, Webb S, Ford B, Cen DZ, Chen SC: Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice. Blood 84:2497, 1994
28. - subpopulation from mobilized peripheral blood. Blood 85:368, 1995
29. Plavec I, Voytovich A, Moss K, Webster D, MBMB, Escaich S, Ho KE, Böhnlein E, DiGiusto DL: Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. Gene Ther 3:717, 1996
30. Nabel GJ, Fox BA, Post L, Thompson CB, Woffendin C: A molecular genetic intervention for AIDS - Effects of a transdominant negative form of Rev. Hum Gene Ther 5:79, 1995
31. Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M: Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp Hematol 18:426, 1990
32. Calenda V, Chermann JC: The effects of HIV on hematopoiesis. Eur J Haematol 48:181, 1992
33. Zauli G, Re MC, Furlini G, Giovannini M, La Placa M: Evidence foi an HIV-1 mediated suppression of in vitro growth of enriched (CD34+) hematopoietic progenitors. J AIDS 4:1251, 1991
34. Cen D, Zauli G, Szarnicki R, Davis BR: Eftect of different human immunodeficiency virus type-1 (HIV-1) isolates on long-term bone marrow haemopoiesis. Br J Haematol 85:596, 1993
35. Geissler RG, Ottmann OG, Kleiner K, Mentzel U, Bickelhaupt A, Hoelzer D, Ganser A: Decreased haematopoietic colony growth in long-term bone marrow cultures of HIV-positive patients. Res Virol 144:69, 1993
36. Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, Merigan TC, Zander A: Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 65:1985, 1991
37. Kaczmarski RS, Davison F, Blair E, Sutherl S, Moxham J, McManus T, Mufti GJ: Detection of HIV in haemopoietic progenitors. Br J Haematol 82:764, 1992
38. Stanley SK, Kessler SW, Justement JS, Schnittman SM, Greenhouse JJ, Brown CC, Musongela L, Musey K, Kapita B, Fauci AS: CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 149:689, 1992
39. Steinberg HN, Anderson J, Crumpacker CS, Chatis PA: HIV infection of the BS-1 human stroma cell line: Effect on murine hematopoiesis. Virology 193:524, 1993
40. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, Boone E, Baseler M, Adelsberger J, Bonyhadi M, Orenstein J, Fox CH, Fauci AS: Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J Exp Med 178:1151, 1993
41. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat Med 1:129, 1995
42. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, Rabin L, McCune JM: HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2:25, 1995
43. Miyazaki Y, Takamatsu T, Nosaka T, Fujita S, Martin TE, Hatanaka M: The cytotoxicity of human immunodeficiency virus type 1 Rev: Implications for its interaction with the nucleolar protein B23. Exp Cell Res 219:93, 1995
44. Akkina RK, Rosenblatt JD, Campbell AG, Chen IS, Zack JA: Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393, 1994
45. Challita PM, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567, 1994
46. Correll P, Colilla S, Karlsson S: Retroviral vector design for long-term expression in murine hematopoietic cells in vivo. Blood 84:1812, 1994
47. Naviaux RK, Verma IM: Retroviral vectors for persistent expression in vivo. Curr Opin Biotechnol 3:540, 1992
48. Williams DA: Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer. Hum Gene Ther 1:229, 1990
49. Frazier AL, Garcia JV: Retrovirus-mediated transfer and long-term expression of HIV type 1 tat gene in murine hematopoietic tissues. AIDS Res Hum Retroviruses 10:1517, 1994